Polaryx Therapeutics Inc. PLYX shares are up on Tuesday as the company has made significant strides in advancing its clinical programs. The positive movement follows the announcement that Polaryx has ...
Polaryx Therapeutics, Inc. (Nasdaq: PLYX), a clinical-stage biotechnology company developing novel, disease-modifying therapies for rare, pediatric lysosomal storage disorders (“LSDs”), announces it ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results